NAD Refers Advertising For Central Coast Nutraceuticals “Colotox” To FTC, FDA For Review
New York, NY – Feb. 9, 2009 – The National Advertising Division of the Council of Better Business Bureaus will refer advertising for Central Coast Nutraceuticals “Colotox” to the Federal Trade Commission (FTC) and Food and Drug Administration (FDA) for further review, following the company’s failure to respond to an NAD inquiry.
NAD, the advertising industry’s self-regulatory forum, examines claims in national advertising for truth and accuracy. As a part of its ongoing monitoring program and in conjunction with NAD’s initiative with the Council for Responsible Nutrition to expand review of advertising for dietary-supplement products, NAD requested from Central Coast Nutraceuticals substantiation of certain Internet advertising claims from FRS.
NAD requested substantiation for express claims that include the following:
“COLOTOX will help to/with:
- Remove toxic buildup
- Increase your energy levels
- Cleanse your entire system
- Decrease gas and bloating
- Reduce water retention
- Detoxify your organs
- Give you radiant hair, skin and nails
- Bad breath
- Lose excess weight
COLOTOX will help relieve these ailments:
- Chronic Fatigue
- Low energy levels
- Constipation
- Bloating
- Bad Breath
- Detoxify your organs
- Excess Weight you just can’t seem to lose”
COLOTOX is the “purest and most effective cleansing product on the market today.”
NAD also requested substantiation for the implied claims related to colon-cancer prevention, including:
- Colon cancer is currently the second leading cancer killer in the United
States, with 60,000 Americans expected to die from the disease this year. - “An estimated 150,000 people in America will be diagnosed with colorectal cancer this year, and while progress is being made to prevent and treat the disease, tragically more than 57,000 will die from it?
- “Colon cancer is one of the deadliest diseases to affect Americans?
- “The Early Show medical correspondent Dr. Emily Senay reports that an average of 57,000 Americans die each year from colon cancer?
- “When colon cancer is caught late, it is survivable only 8 percent of the time?
NAD, which made several attempts to contact the advertiser, noted that it was disappointed the advertiser did not respond to the NAD’s inquiry, “especially in light of the strong health-related and weight-loss claims being made in the advertising. Pursuant to its procedures, NAD has referred the matter to the appropriate federal agencies.
Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.
Latest Decisions
National Advertising Division Recommends T-Mobile Discontinue or Modify 20% Savings vs. ‘The Other Big Guys’ Claim; T-Mobile to Appeal
New York, NY – January 9, 2025 – The National Advertising Division recommended that T-Mobile discontinue or modify its advertising to avoid conveying the comparative claim that consumers can “save 20% every month vs. the other big guys” if they subscribe to T-Mobile in markets where Spectrum Mobile also...
In National Advertising Division Fast-Track SWIFT Challenge Behr Voluntarily Discontinues “No Comparable Product” Claim
New York, NY – January 8, 2025 – In a National Advertising Division Fast-Track SWIFT challenge brought by Benjamin Moore, Behr voluntarily discontinued its “No Comparable Product” claim.
National Advertising Division Finds Charter’s “Unlimited” Claims Supported; Recommends Clear & Conspicuous Speed Limitation Disclosures
New York, NY – January 7, 2025 – The National Advertising Division found that Charter substantiated certain express and implied claims about its Spectrum Mobile “Unlimited” and “Unlimited Plus” wireless data plans but recommended that Charter modify its website advertising to disclose high speed data...
National Advertising Division Recommends Solawave Discontinue Certain Claims for its Advanced Skincare Wand
New York, NY – January 6, 2025 – As part of its routine monitoring process, the National Advertising Division recommended Solawave discontinue certain express and implied claims for its SolaWave Advanced Skincare Wand.